Related references
Note: Only part of the references are listed.Receptor binding competition: A paradigm for regulating TGF-β family action
Erik Martinez-Hackert et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2021)
Inhibition of TGF-β Increases Bone Volume and Strength in a Mouse Model of Osteogenesis Imperfecta
Benjamin Greene et al.
JBMR PLUS (2021)
Combination therapy in the Col1a2G610C mouse model of Osteogenesis Imperfecta reveals an additive effect of enhancing LRP5 signaling and inhibiting TGFβ signaling on trabecular bone but not on cortical bone
Shannon Kaupp et al.
BONE (2020)
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies
Julius Strauss et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors
Jessica J. Tao et al.
CLINICAL CANCER RESEARCH (2019)
Osteogenesis imperfecta: advancements in genetics and treatment
Vittoria Rossi et al.
CURRENT OPINION IN PEDIATRICS (2019)
Genetic approaches to metabolic bone diseases
Fadil M. Hannan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Mammary Precancerous Stem and Non-Stem Cells Evolve into Cancers of Distinct Subtypes
Wen Bu et al.
CANCER RESEARCH (2019)
Effect of Anti-TGF-β Treatment in a Mouse Model of Severe Osteogenesis Imperfecta
Josephine T. Tauer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Current concepts in osteogenesis imperfecta: bone structure, biomechanics and medical management
W. H. Nijhuis et al.
JOURNAL OF CHILDRENS ORTHOPAEDICS (2019)
A Multicenter Observational Cohort Study to Evaluate the Effects of Bisphosphonate Exposure on Bone Mineral Density and Other Health Outcomes in Osteogenesis Imperfecta
Jaskaran S. Bains et al.
JBMR PLUS (2019)
Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer
Silvia C. Formenti et al.
CLINICAL CANCER RESEARCH (2018)
A multicenter study to evaluate pulmonary function in osteogenesis imperfecta
Allison Tam et al.
CLINICAL GENETICS (2018)
BPS804 Anti-Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial
Francis H. Glorieux et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Osteogenesis imperfecta
Joan C. Marini et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Genetic causes and mechanisms of Osteogenesis Imperfecta
Joohyun Lim et al.
BONE (2017)
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis
Flavio Vincenti et al.
KIDNEY INTERNATIONAL REPORTS (2017)
Pharmacological and biological therapeutic strategies for osteogenesis imperfecta
Ronit Marom et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2016)
Efficacy of Bisphosphonates on Bone Mineral Density and Fracture Rate in Patients With Osteogenesis Imperfecta: A Systematic Review and Meta-analysis
Chang Gui Shi et al.
AMERICAN JOURNAL OF THERAPEUTICS (2016)
Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis
Bente Langdahl et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2016)
Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients
Lisa M. Rice et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
A cross-sectional multicenter study of osteogenesis imperfecta in North America - results from the linked clinical research centers
R. M. Patel et al.
CLINICAL GENETICS (2015)
Behavior of Scoliosis During Growth in Children with Osteogenesis Imperfecta
Alireza K. Anissipour et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2014)
Evaluation of teriparatide treatment in adults with osteogenesis imperfecta
Eric S. Orwoll et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Excessive transforming growth factor-β signaling is a common mechanism in osteogenesis imperfecta
Ingo Grafel et al.
NATURE MEDICINE (2014)
Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma
John C. Morris et al.
PLOS ONE (2014)
Bisphosphonate therapy for osteogenesis imperfecta
Kerry Dwan et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I
Davide Gatti et al.
CALCIFIED TISSUE INTERNATIONAL (2013)
Direct assessment of articular cartilage and underlying subchondral bone reveal's a progressive gene expression change in human osteoarthritic knees
C. -H. Chou et al.
OSTEOARTHRITIS AND CARTILAGE (2013)
Osteoporosis: now and the future
Tilman D. Rachner et al.
LANCET (2011)
Characterising and treating osteogenesis imperfecta
Nick Bishop
EARLY HUMAN DEVELOPMENT (2010)
Risedronate in the Treatment of Mild Pediatric Osteogenesis Imperfecta: A Randomized Placebo-Controlled Study
Frank Rauch et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Intracortical remodeling during human bone development - A histomorphometric study
Frank Rauch et al.
BONE (2007)
Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: A 3-year randomized placebo-controlled trial
G Chevrel et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta
LA DiMeglio et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Intravenous neridronate in children with osteogenesis imperfecta:: A randomized controlled study
D Gatti et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: Effect of intravenous pamidronate therapy
F Rauch et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Intravenous neridronate in adults with osteogenesis imperfecta
S Adami et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)